MyMD Pharmaceuticals Inc.

11/18/2021 | Press release | Archived content

MyMD Pharmaceuticals® Investment Company Oravax Medical and Genomma Lab Announce Joint Venture to Develop and Commercialize Oral COVID-19 Vaccine in Mexico and Drive Business[...]

Read this content
Click here to read the original version at the source's official website. The text of this article is not available at the moment.